Furthermore, since the most common and conventional breast cancer diagnosis and treatment techniques tend to focus and target ER, PR and HER2, it is often difficult to detect10 and treat11 TNBCs with conventional targeted hormonal therapy and chemotherapy. This evidence concerns the gene PGR and breast cancer.